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Although impaired fear extinction has repeatedly been demonstrated in patients
with anxiety disorders, little is known about whether these impairments persist after
treatment. The current comparative exploratory study investigated fear extinction in
26 patients treated for their anxiety disorder in the years preceding the study as
compared to 17 healthy control subjects. Fear-potentiated startle and subjective fear
were measured in a cue and context fear conditioning paradigm within a virtual reality
environment. Results indicated no differences in fear extinction between treated anxiety
patients and control subjects. However, scores on the Beck Anxiety Inventory across all
participants revealed impaired extinction of fear potentiated startle in subjects with high
compared to low anxiety symptoms over the past week. Taken together, this exploratory
study found no support for impaired fear extinction in treated anxiety patients, and
implies that current anxiety symptoms rather than previous patient status determine
the success of extinction.
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INTRODUCTION
Fear extinction serves as a potential model to explain the development, maintenance and treatment
of anxiety disorders, and extinction of fear has been studied extensively in patients with anxiety
disorders over the past decades. Support for the role of impaired fear extinction in the development
of post-traumatic stress disorder was found in prospective studies, in which stronger fear responses
during extinction predicted the onset of posttraumatic stress symptoms at a later stage (Guthrie
and Bryant, 2006; Orr et al., 2012; Lommen et al., 2013). We recently published a meta-analysis
that provided evidence for the role of impaired fear extinction in patients with a current anxiety
disorder (Duits et al., 2015). Robustly higher fear responses to danger cues (CS+’s) and stronger
diﬀerentiation between danger and safety cues (CS+ and CS–) were demonstrated in patients with
anxiety disorders compared to healthy subjects during extinction (Duits et al., 2015). Support for
the predictive value of fear extinction on treatment outcome was found in recent studies conducted
in patients with panic disorder and agoraphobia (Kircher et al., 2012; Lueken et al., 2013; Hahn
et al., 2014). Treatment non-responders displayed enhanced activation of threat-related brain
systems in response to safety cues during extinction when compared to responders (Lueken et al.,
2013).
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Although many studies have investigated diﬀerences in
fear extinction between patients with anxiety disorders and
healthy control subjects, little is known about whether impaired
extinction of fear persists in patients who have been treated
for an anxiety disorder earlier in their life. Persistent reduced
extinction of fear would suggest that performance on extinction
tasks represents an endophenotypic trait rather than a temporary
condition. Indeed, individual diﬀerences in fear extinction seem
to be moderately heritable (Hettema et al., 2003) and fear
acquisition (Zeidan et al., 2012; Torrents-Rodas et al., 2014)
and extinction (Fredrikson et al., 1993) parameters seem to be
relatively stable over time. The relative stability of conditioning
parameters supports the idea that patients with an anxiety
disorder will not only demonstrate impaired extinction of
fear at the time of their illness, but also after treatment
and later in life. However, on the other hand, some studies
suggest that brain mechanisms underlying fear extinction might
strengthen over time as a consequence of exposure-based
cognitive behavioral treatment in patients with anxiety disorders,
suggesting changeability of these mechanisms related to fear
extinction mechanisms (Kircher et al., 2012; Galvao-de et al.,
2013).
The current study aimed to explore diﬀerences in the
extinction of fear responses between treated anxiety patients
and healthy control subjects. Startle responses as well as
subjective fearfulness were measured to assess whether any group
diﬀerences exist in cue-speciﬁc fear responses (as previously
demonstrated by Lissek et al., 2005 and Duits et al., 2015),
contextual-speciﬁc fear responses (Grillon et al., 2008, 2009) and
generalization of fear during extinction. In accordance with a
dimensional transdiagnostic approach (as initiated by the NIMH
in their Research Domain Criteria; RDoC; Insel et al., 2010), we
assessed fear responding as well as current anxiety symptoms as
continuous variables across two closely related diagnostic groups
(see Materials and Methods) and a control group. Considering
that fear extinction has been shown to be partly genetically
determined and relatively stable over time, we hypothesized that
patients who have been treated for an anxiety disorder in the
past would still show stronger fear responses during extinction
learning to both the threat cue and threat context, and show
stronger generalization of fear responses, as compared to healthy
control subjects. This paper focusses on the extinction of fear,
but fear acquisition data are also reported as potential diﬀerences
in fear acquisition may confound subsequent analyses on the
extinction of fear.
MATERIALS AND METHODS
Participants
Thirty anxiety patients were recruited via Altrecht Academic
Anxiety Centre in Utrecht, a specialized outpatient clinic for
anxiety disorders. Four patients were excluded from further
analyses, as these patients used benzodiazepines and /or
antipsychotics at time of participation, which can substantially
inﬂuence fear responses during the conditioning procedure
(Baas et al., 2002; Brignell and Curran, 2006). Patients had
been primarily diagnosed with either a panic disorder with
agoraphobia (N = 13) or a generalized social anxiety disorder
(N = 13). Both panic disorder with agoraphobia and social
anxiety disorder belong to the main types of phobic disorders
(Antony and Swinson, 2000). We investigated these two types
of phobic disorders concomitantly (Liberman et al., 2006;
Lau et al., 2008; Reeb-Sutherland et al., 2009; Waters et al.,
2009), as the underlying theory assumes that delayed and/or
reduced extinction of fear cuts across the diagnostic categories
of phobic disorders. All diagnoses had been established prior to
treatment according to DSM-IV classiﬁcation criteria (American
Psychiatric Association, 2000), with the aid of the Structured
Clinical Interview for DSM-IV-TR Axis I Disorders (First et al.,
2002). Ninety-two percent (n = 24) of the patients had a
comorbid diagnosis, see Supplementary Table S1 for a list of
comorbid diagnoses in the patient group before therapy.
All included patients had received exposure therapy with
response prevention (ERP) at the outpatient clinic between 2008
and 2012. In 12 patients ERP was combined with serotonin
reuptake inhibitors. Fourteen of the included patients were
medication-free, one patient used methylphenidate combined
with a serotonin-reuptake inhibitor.
Time period between treatment and participation in the
fear conditioning experiment of this study ranged between
2 months and 4 years (M = 1.4 years, SD = 1.1). ERP (with
or without pharmacotherapy) encompassed an average of 18
(SD = 8) 45-min sessions. Treatment focused on reducing panic
or social anxiety symptoms and avoidance behavior by cognitive
therapeutic techniques, interoceptive exposure, and exposure to
the feared situations.
Treatment outcome in patients with panic disorder and
agoraphobia was measured using the Body Sensations
Questionnaire (BSQ; Chambless et al., 1984). On average,
patients with panic disorder and agoraphobia demonstrated
21% improvement of their anxiety symptoms (measured using
BSQ mean scores) between pre- and post-treatment, and 11%
improvement when comparing pre-treatment symptoms with
symptoms at the time of participation in the current study. Six
patients were in full remission, with scores below the cutoﬀ
criterion of 1.93 (using the BSQ), at time of participation and
at time of post-treatment measurement (de Beurs, 1993). The
Social Phobia and Anxiety Inventory 18-item version (SPAI-18;
Beidel et al., 1989) was used to assess treatment outcome in
patients with social anxiety disorder. Patients with social phobia
showed on average 14% improvement between pre-treatment
and post-treatment, and 26% improvement when comparing
pre-treatment symptoms with symptoms at time of participation
in the current study. Based on a cutoﬀ criterion of 48 (de Vente
et al., 2014), treatment eﬀects were clinically signiﬁcant in four
treated patients with social anxiety disorder (31%) at time of
participation in the current study and in three patients (23%) at
time of post-treatment.
Twenty age-, sex-, and education-matched healthy control
subjects (see Table 1) were recruited through advertisements
in supermarkets and community centers. Healthy controls
were free of psychotropic medication, and were screened
on the absence of lifetime axis I diagnoses using the Mini
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TABLE 1 | Demographic characteristics of the patient and control group.
Patient group (N = 26) Control group (N = 17) Significance of group
differencesa
N % N %
Male 19 73.1 13 76.5 NS
Female 7 26.9 4 23.5 NS
Medication 12 46.2 0 0 p = 0.001
Mean SD Mean SD
Age 34.7 9.5 35.2 10.2 NS
aChi-square tests (except for age, which was assessed using a two-tailed independent samples t-tests).
International Neuropsychiatric Interview (Van Vliet and De
Beurs, 2007). Three control subjects (and none of the patients)
were excluded as they failed to indicate in which context the
shocks were administered during uninstructed acquisition (see
also Supplementary Material). The ﬁnal sample consisted of 17
healthy control subjects. Exclusion of the three context-unaware
control subjects did not signiﬁcantly alter the results of the
current study.
Experimental procedures were approved by the Medical
Research Ethics Committee of the University Medical Centre
Utrecht. Participants were informed about the current study by
telephone and by means of an information letter. Subsequently,
all participants were asked whether they had hearing problems,
to ensure that participants would respond to the startle probes
in the experiment. Written informed consent was given by all
participants, and all subjects received a ﬁnancial compensation
for their time while participating in the experiment (between €
25,− and € 35,−).
Symptom Ratings at Time of Testing
The following questionnaires were completed by all subjects
to measure presence and severity of symptoms of anxiety
and depression at testing: the Beck Anxiety Inventory (BAI;
Beck et al., 1988), the Anxiety Sensitivity Index (ASI; Peterson
and Heilbronner, 1987; Rodriguez et al., 2004), and the Beck
Depression Inventory – II (BDI; Beck et al., 1961). The
BAI questionnaire (containing 21 items) focusses mainly on
physiological symptoms of anxiety that have been present over
the past week including the day of participating in the study
(Beck et al., 1988), while the 16-item ASI assesses a subjects’ belief
about the consequences of their anxiety symptoms. The trait
subscale of the State-Trait Anxiety Inventory (STAI; Spielberger
et al., 1983) was included to assess trait anxiety. Patients formerly
diagnosed with panic disorder and agoraphobia completed the
BSQ (Chambless et al., 1984), while patients with social anxiety
disorder ﬁlled out the SPAI-18 (Beidel et al., 1989) to follow them
on speciﬁc symptom change. Control subjects completed both
the BSQ and SPAI-18 to optimize comparability with the patient
group at testing (Table 2).
The Conditioning Procedure
The experimental procedure was conducted in a sound-insulated
laboratory with dimmed light. Participants were seated in front
of a computer screen and surface electrodes were attached to
measure the eyeblink startle reﬂex. We used the well-established
virtual reality fear conditioning task developed by Baas et al.
(2004, 2008), Heitland et al. (2012), and Baas (2013), with the
same design as in Heitland et al. (2012). Participants viewed
prerecorded movies in a virtual environment consisting of scenes
from two diﬀerent contexts: an apartment and a suburban house.
The conditioned stimulus (CS) consisted of an 8-s duration subtle
increase in background illumination. The CS was presented
four times in each context per block. In one context (threat;
counterbalanced across subjects), presentation of the CS could
be paired with the unconditioned stimulus (US), which was
an electrical shock. The US was presented co-terminating with
the CS oﬀset and never at other times. In the other context
(safe), presentation of the CS was never paired with the US.
TABLE 2 | Symptom ratings in the patient and control group.
Patient group (N = 26) Control group (N = 17) Significance of group
differencesa
Mean SD Mean SD
Anxiety Sensitivity Index (ASI) 17.4 10.4 5.8 4.5 p < 0.001
Beck Anxiety Inventory (BAI) 12.2 8.8 4.9 4.7 p = 0.008
Beck Depression Inventory (BDI) 12.6 10.4 6.2 7.4 p = 0.036
STAI – trait 48.4 7.4 41.2 5.6 p = 0.004
BSQ at testing 2.2 0.9 1.4 0.4 p = 0.010
BSQ before treatment 2.7 0.7 − − NA
SPAI-18 at testing 54.8 13.9 34.6 15.2 p = 0.001
SPAI-18 before treatment 73.8 10.0 − − NA
aTwo-tailed independent samples t-tests.
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FIGURE 1 | Examples of screenshots from the fear conditioning task.
The upper two screenshots show the apartment with the light on and off. The
lowest screen shots present the suburban house with the light on and off.
This created four diﬀerent conditions: shock context light on,
shock context light oﬀ, safe context light on and safe context
light oﬀ (see Figure 1). The two contexts were connected to each
other by short scenes in the metro and the street. A shock work
up procedure was completed prior to the conditioning task to
establish an individual shock level that was perceived as ‘quite
annoying but not painful’ by each participant. Subjective ratings
of shock aversiveness were obtained after each block.
The fear conditioning task consisted of 16 blocks. Each block
lasted 5.25 min and started with a short scene in the metro and
street in which three startle probes were presented for habituation
of the startle reﬂex. All blocks included one long visit to the
shock or safe context and two short visits to the shock or safe
context (Baas et al., 2008). There were four CS presentations in
each context, regardless of whether the context was visited once
(duration was 90 s, including four CS presentations) or twice
(visit durations were 70 s and 30 s, including three and one CS
presentation, respectively). In each block, during three out of four
CS presentations per context a startle probe was presented, as well
as three probes in absence of the CS in each context (see Figure 2).
Scenes of the metro and the street were displayed for 40 s during
the transition between visits. Each metro/street scene contained
two startle probes, to prevent dishabituation of the startle.
Similar to Heitland et al. (2012), the experiment consisted
of four distinct phases: habituation (one block), uninstructed
acquisition (six blocks), instructed acquisition (ﬁve blocks),
and extinction (four blocks). The habituation phase consisted
of 12 startle probe presentations, followed by a video to get
acquainted to the virtual environment. Prior to the uninstructed
acquisition phase, subjects were told that from now on, they
could receive shocks and that they might be able to predict the
onset of these shocks by watching the movie scenes carefully.
This uninstructed acquisition phase was designed to measure
the spontaneous learning of cue and context associations with
the shock occurrence. At the end of the uninstructed acquisition
phase, all subjects were asked to report on what they considered
to predict the onset of the shock. Groups did not diﬀer
in contingency awareness (additional data in Supplementary
Table S2). At the start of the instructed acquisition phase, subjects
received an explicit verbal and written on-screen instruction in
which the speciﬁc contingency between danger context, CS, and
US was described. The instructed phase was included in the
paradigm to assess responses once contingencies were acquired,
and to ensure contingency learning before extinction started.
During both acquisition phases, some blocks (1, 3, 4, and 7)
contained relatively high (75%) reinforcement rates to ensure
acquisition, while other blocks (2, 5, 6, 8, 9, 10, and 11)
contained low (37,5%) rates of reinforcement. During the low
reinforcement blocks, the shock was given during the last CS
of that visit (i.e., the ﬁrst, third or fourth CS, depending on
whether it relates to a long or two short visits of the shock
context within that block). Blocks with low reinforcement rates
were introduced to minimize the eﬀects of shock sensitization
on physiological responding, which is especially relevant for the
unbiased assessment of context responses (Baas et al., 2008; Baas,
2013). Psychophysiological measures are only reported from the
blocks with the low reinforcement rates, as in these blocks startle
probes do not follow directly upon a shock presentation in the
shock context, and the safe context is visited equally often as the
shock context after shock reinforcement. The extinction phase,
in which the CS was no longer paired with the US in the shock
context, followed immediately after the instructed acquisition
and started without explicit instructions.
Stimuli and Physiological Apparatus
Electrical shocks were administered by a Digitimer DS7A
generator. The shock electrodes were applied over the medial
nerve on the inner left wrist. A train of 125 pulses of 2-ms length
served as US, lasting for 625 ms.
The startle probes were 50-ms, 105 dB (A) white-noise bursts
delivered through headphones (Sennheiser Electronic HD 202).
The electromygraphic (EMG) activity associated with each startle
trial was recorded with two Ag/AgCl electrodes on the orbicularis
oculi under the right eye, using a Biosemi ActiveTwo system
(BioSemi Instrumentation, Amsterdam, The Netherlands).
Subjective Fear Ratings
Subjective fearfulness ratings were obtained after each block
during uninstructed acquisition, instructed acquisition, and
extinction. The measurement was conducted using visual analog
scales (VAS) that were presented on the computer. Screenshots
frommovie clips (randomly drawn from a set of 10 per condition,
see Figure 1 for examples) were presented simultaneously with
the VAS scale, with the instruction to rate the level of fear
associated with the given situation [anchors were ‘not at all fearful
of shock’ (0) and ‘very fearful of shock’ (100)]. Each condition was
presented twice (using diﬀerent screenshots) after every block
to allow a reliable assessment of subjects’ fearfulness ratings per
condition.
Data Reduction
Brain Vision Analyzer software was used to process the
startle data according to published guidelines and previous
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FIGURE 2 | Schematic representation of the conditioning paradigm, including the task design (A) and the structure of a single block (B). This figure is
adapted from Heitland et al. (2013).
studies (Blumenthal et al., 2005; Baas et al., 2008; Baas,
2013). For detailed information regarding startle processing and
identiﬁcation of artifacts and null responses, see Böcker et al.
(2004). Potential diﬀerences in baseline startle amplitudes and
shock intensity between treated anxiety patients and control
subjects were investigated ﬁrst, as these were regarded as potential
confounds during extinction. For all subsequent analyses, startle
amplitudes were transformed into z-scores = (raw score –
mean of all startle trials within each subject)/standard deviation
to control for individual pre-existing diﬀerences in baseline
startle amplitudes. Thereafter, mean startle amplitudes were
computed per condition per block (average of three raw startle
amplitudes). Only startle data from the acquisition blocks
with low (37.5%) reinforcement shock rates (blocks 2, 5, 6,
8, 9, 10, 11), and all extinction blocks (blocks 12, 13, 14,
15) were included in the analyses to prevent contamination
of the data by shock sensitization. Participants’ physiological
data were included in the ﬁnal analysis if at least one artifact-
free trial for each block was recorded per stimulus type.
Startle data from one control subject was missing in the ﬁnal
analyses.
Statistical Analyses
Analyses were consistent with previous, similar fear conditioning
studies (Heitland et al., 2012, 2013), and were conducted
with IBM SPSS Statistics (version 20.0). Fear potentiation was
studied using cue-speciﬁc, context-speciﬁc, and generalization
contrasts. First, cue-speciﬁc fear responses were calculated
by subtracting fear responses to the shock room light vs.
shock room dark. Second, context-speciﬁc fear responses
were computed by contrasting fear responses to the shock
room dark vs. safe room dark. Third, generalization of fear
was calculated by subtracting shock room light vs. safe
room light. Startle and subjective outcome measurements
were analyzed separately per phase (uninstructed acquisition,
instructed acquisition, and extinction) using repeated measures
General Linear Model (GLM) Analyses of Variance (ANOVAs).
To assess the reduction of fear potentiation of startle and
VAS responding during extinction, late acquisition (the last
two blocks during instructed acquisition) was contrasted to late
extinction (blocks 14 and 15; where the eﬀect of extinction
over time becomes apparent). Group, deﬁned as treated anxiety
patients vs. healthy controls, was included in the ANOVA’s
as between-subjects factor. Within-subject factors were block
and cue-speciﬁc fear-potentiated startle (FPS)/context-speciﬁc
FPS/generalization FPS.
Follow-Up Analyses
Subsequently, in case of a signiﬁcant interaction between cue-
speciﬁc FPS/context-speciﬁc FPS/generalization FPS and group,
follow up analyses were conducted per contrast to determine
the nature of the eﬀect. First, the change in fear-response over
time was examined per group, to assess whether acquisition
or extinction learning took place within each group. Second,
diﬀerences in fear responding were tested between groups during
the ﬁrst and last two blocks of the phase, to investigate within-
phase changes in fear responding.
Covariates
Medication use was added as between-subjects variable in all
GLM analyses described above, to control for (1) the unequal
distribution of medication use between groups and (2) potential
eﬀects of medication on fear conditioning. In addition, we
controlled for individual diﬀerences in anxiety symptoms at
time of participation, because higher rates of anxiety symptoms
may lead to stronger fear responses during extinction (Grillon
et al., 1993; Jackson et al., 2006; Vriends et al., 2010). Moreover,
anxiety symptoms at the time of participating may diﬀer
substantially across patients treated for an anxiety disorder,
because the time between treatment and participating in the
current paradigm was not standardized. The BAI (Beck et al.,
1988) was included as continuous covariate to control for
diﬀerences in anxiety symptoms at time of participation. In
case a signiﬁcant interaction between BAI and cue-speciﬁc
FPS/context-speciﬁc FPS/generalization FPS was found in the
main analyses, follow up analyses were conducted to determine
the nature of these interaction eﬀects and to allow visualization
of the eﬀects. Therefore, participants were categorized as subjects
Frontiers in Psychology | www.frontiersin.org 5 February 2016 | Volume 7 | Article 252
Duits et al. Fear Extinction in Treated Anxiety Patients
with high (BAI > 9) vs. low (BAI 0–9) anxiety symptoms over
the past week. The cut-oﬀ to index anxiety symptoms at testing
(BAI = 9) was based on a median split, which corresponds to
the cut score that has been recommended by other studies that
investigated psychometric properties of the BAI and the utility of
this questionnaire as a screener for anxiety disorders (Kabacoﬀ
et al., 1997; Leyfer et al., 2006). High (N = 15) as well as low
(N = 10) BAI scores were observed in the treated patient group.
Furthermore, 10 control subjects reported low anxiety symptoms
over the past week, while three control subjects had high anxiety
symptoms. BAI scores from one patient and four control subjects
were missing. See Supplementary Table S3 for the distribution
of clinically relevant anxiety symptoms (based on cut oﬀ scores
from symptom speciﬁc questionnaires) across subjects with high
vs. low anxiety symptoms.
Additional Analyses
Last, GLM ANOVA’s were also conducted to investigate
diﬀerences in fear extinction between treatment responders vs.
non-responders. Cutoﬀ scores from the BSQ and SPAI-18 were
used for the grouping of responders and non-responders. No
signiﬁcant group diﬀerences in fear conditioning were found
between responders (N = 7) and non-responders (N = 18). Data
pertaining to this line of analyses is available upon request.
RESULTS
Shock Work Up
Group diﬀerences in shock intensity were tested to assess
whether this basic parameter could account for group
diﬀerences. Independent samples t-tests demonstrated no
signiﬁcant diﬀerences in the ﬁnal shock intensity that was
established after the shock work up between treated anxiety
patients (M = 1.5 mA, SD = 0.6) and controls (M = 1.9 mA,
SD = 1.1), t(41) = –1.09, p = 0.286, d = –0.45. Furthermore,
a repeated measures ANOVA demonstrated no signiﬁcant
diﬀerence in self-reported VAS ratings of shock aversiveness
(measured after each block) between treated anxiety patients and
controls (main eﬀect group: F(1,41) = 1.4, p = 0.244, η2p = 0.03;
group by stimulus interaction: F(4.6,190.3) = 0.8, p = 0.556,
η2p = 0.02).
Baseline Startle Amplitude
Group diﬀerences in baseline startle amplitudes were investigated
to control for pre-existing group diﬀerences prior to the
conditioning procedure. Results demonstrated signiﬁcantly
higher baseline startle amplitudes in the treated patient group
(M = 114.1 μV, SD = 50.1), as compared to controls during
startle habituation series (M = 74.9 μV, SD = 44.), F(1,41)= 7.1,
p = 0.011, η2p = 0.15. Analyses of the FPS during conditioning
were performed with z-transformed values to correct for
individual baseline diﬀerences (see Data Reduction).
Startle
Startle – Task Effects
Signiﬁcant cue-speciﬁc FPS (shock room light vs. shock room
dark), context-speciﬁc FPS (shock room dark vs. safe room
dark) and generalization FPS (shock room light vs. safe room
light) were demonstrated across subjects during uninstructed
acquisition, instructed acquisition and extinction, as shown in
Table 3. These main eﬀects of cue, context and generalization
support the validity of our conditioning paradigm. Startle data
across participants are shown in Figure 3.
TABLE 3 | Main effects of cue, context and generalization: startle data and subjective fearfulness ratings.
df F p η2p Observed power
Fear potentiated startle
Uninstructed acquisition Cue 1, 40 6.5 0.015 0.139 0.70
Context 1, 41 18.6 0.001 0.31 0.99
Generalization 1, 40 34.6 0.001 0.464 1.00
Instructed acquisition Cue 1, 41 90.5 0.001 0.69 1.00
Context 1, 41 79.2 0.001 0.66 1.00
Generalization 1, 41 125.8 0.001 0.754 1.00
Extinction Cue 1, 41 88.7 0.001 0.684 1.00
Context 1, 41 48.1 0.001 0.540 1.00
Generalization 1, 41 123.9 0.001 0.751 1.00
Subjective fearfulness
Uninstructed acquisition Cue 1, 41 5.0 0.030 0.11 0.59
Context 1, 41 35.4 0.001 0.46 1.00
Generalization 1, 41 43.3 0.001 0.51 1.00
Instructed acquisition Cue 1, 41 31.2 0.001 0.43 1.00
Context 1, 41 25.2 0.001 0.38 1.00
Generalization 1, 41 61.3 0.001 0.60 1.00
Extinction Cue 1, 41 19.6 0.001 0.32 0.99
Context 1, 41 23.2 0.001 0.36 1.00
Generalization 1, 41 52.4 0.001 0.56 1.00
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FIGURE 3 | Startle data (Z-scores) across all participants shown separately for shock room light, shock room dark, safe room light, and safe room
dark. No significant differences between treated anxiety patients and control subjects were found. Error bars show ±1 SEM.
Startle Amplitudes During Acquisition
There were no signiﬁcant diﬀerences between treated anxiety
patients and control subjects in cue-speciﬁc FPS during both the
uninstructed, F(1,33) = 0.1, p = 0.923, η2p = 0.01, and instructed
acquisition phase, F(1,34) = 0.1, p = 0.944, η2p = 0.01. Context-
speciﬁc FPS was neither signiﬁcantly diﬀerent in treated anxiety
patients compared to control subjects during uninstructed,
F(1,34) = 0.1, p = 0.863, η2p = 0.01, and instructed acquisition
of fear, F(1,34) = 2.4, p = 0.132, η2p = 0.07. In addition, there
were no signiﬁcant patient-control diﬀerences in generalization
FPS during the uninstructed, F(1,33)= 0.8, p = 0.383, η2p = 0.02,
and instructed acquisition phase, F(1,34) = 0.1, p = 0.739,
η2p = 0.01. These non-signiﬁcant diﬀerences in fear acquisition
between treated anxiety patients and control subjects imply that
it is not likely that potential group diﬀerences in fear extinction
are confounded by pre-existing group diﬀerences.
Results from the main analysis demonstrated a signiﬁcant
interaction between covariate BAI, generalization FPS (shock
room light vs. safe room light), and block during instructed
acquisition, F(2.9,98.8) = 4.0, p = 0.010, η2p = 0.11. Follow up
analyses demonstrated a signiﬁcant increase of generalization
FPS between early instructed and late instructed acquisition in
subjects with low anxiety symptoms at time of participation,
F(1,18) = 5.1, p = 0.036, η2p = 0.22. This eﬀect was
marginally signiﬁcant in subject with high anxiety symptoms,
F(1,16) = 3.9, p = 0.064, η2p = 0.20. There was no signiﬁcant
diﬀerence between subjects with high vs. low current anxiety
symptoms on generalization FPS during early (F = 0.330,
p = 0.569) or late instructed acquisition (F = 0.278,
p = 0.601). See also Supplementary Figure S1 for the startle
data, shown separately for subjects with high and low anxiety
symptoms.
Startle Amplitudes During Extinction
From late acquisition to late extinction, no signiﬁcant diﬀerences
were found between treated anxiety patients and control subjects
in cue-speciﬁc FPS, F(1,34) = 0.3, p = 0.606, η2p = 0.01,
context-speciﬁc FPS, F(1,34) = 0.3, p = 0.575, η2p = 0.01, and
generalization FPS, F(1,34)= 0.1, p= 0.766, η2p = 0.01. However,
covariate BAI did signiﬁcantly interact with cue-speciﬁc FPS,
context-speciﬁc FPS and generalization FPS. These interaction
eﬀects, as well as subsequent follow up analyses, are described
below per contrast (see also Supplementary Figure S1).
Cue-specific FPS
There was a signiﬁcant 3-way interaction between cue-speciﬁc
FPS, block, and covariate BAI. Follow-up analyses with BAI as
between-subjects factor demonstrated signiﬁcantly higher cue-
speciﬁc FPS in subjects with high compared to low anxiety
symptoms during late extinction, F(1,35) = 13.0, p = 0.001,
η2p = 0.27; Figure 4A. There was no signiﬁcant reduction of cue-
speciﬁc FPS throughout extinction (from late acquisition to late
extinction) in subjects reporting low and high anxiety symptoms
over the past week, F(1,18) = 2.7, p = 0.116, η2p = 0.13 and
F(1,16) = 4.0, p = 0.06, η2p = 0.20, respectively.
Context-specific FPS
Main analyses demonstrated a signiﬁcant interaction between
context-speciﬁc FPS and covariate BAI. However, no signiﬁcant
diﬀerences in context-speciﬁc FPS were found during late
extinction between those subjects reporting high vs. low anxiety
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FIGURE 4 | (A) Significant stronger cue-specific fear-potentiated startle (FPS; shock room light vs. shock room dark) during late extinction in subjects with high as
compared to low anxiety symptoms. (B) No significant differences in context-specific FPS (shock room dark vs. safe room dark) between subjects reporting high vs.
low anxiety symptoms over the past week. Error bars show ±1 SEM. ∗p < 0.05.
FIGURE 5 | Generalization FPS (shock room light vs. safe room light) in
subjects with high vs. low anxiety symptoms. Error bars show ±1 SEM.
∗p < 0.05; #p = 0.051.
symptoms, F(1,35) = 2.3, p = 0.137, η2p = 0.06 (Figure 4B).
There was also no signiﬁcant decrease of context-speciﬁc FPS
throughout extinction in subjects with low, F(1,18) = 1.42,
p = 0.249, η2p = 0.07, or high anxiety symptoms, F(1,16) = 0.04,
p = 0.842, η2p < 0.01.
Generalization FPS
There was a signiﬁcant interaction between generalization FPS
and covariate BAI. Follow-up analyses, with BAI included
as between-subjects factor, demonstrated signiﬁcantly higher
generalization FPS during late extinction in subjects with high
compared to low anxiety symptoms at the time of participation,
F(1,35) = 23.3, p < 0.001, η2p = 0.40; Figure 5. Furthermore,
there was a marginally signiﬁcant reduction of generalization
FPS from late acquisition to late extinction in subjects with low
anxiety symptoms, F(1,18) = 4.4, p = 0.051, η2p = 0.20, but not
in subjects with high anxiety symptoms, F(1,16)= 1.7, p= 0.210,
η2p = 0.10.
Subjective Fearfulness Ratings
Signiﬁcant main eﬀects of cue (shock room light vs. shock
room dark), context (shock room dark vs. safe room dark)
and generalization (shock room light vs. safe room light)
were demonstrated during uninstructed acquisition, instructed
acquisition and extinction across subjects, as shown in Table 3.
No signiﬁcant patient-control diﬀerences were found in cue-
speciﬁc, context-speciﬁc, or generalization contrasts of VAS
fearfulness ratings during acquisition and extinction phases
(all p values > 0.50). In addition, medication use (between-
subjects factor) and BAI (covariate) did not signiﬁcantly interact
with cue-speciﬁc FPS/context-speciﬁc FPS or generalization FPS.
Subjective fearfulness ratings across all participants are shown in
Figure 6.
DISCUSSION
The current study aimed to explore diﬀerences in fear extinction
between treated anxiety disordered patients and healthy control
subjects. Speciﬁcally, the current explorative study aimed to gain
more insight in whether impaired fear extinction is present in
patients who have been treated for an anxiety disorder in the past.
Results demonstrated a signiﬁcantly stronger baseline startle
reﬂex in treated anxiety patients as compared to control subjects
during the habituation phase, which is in line with earlier
ﬁndings in patients with panic disorder (Ludewig et al., 2005).
Based on previously demonstrated patient-control diﬀerences
in the extinction of fear (Duits et al., 2015) and based on the
relative stability of extinction parameters (Fredrikson et al., 1993;
Hettema et al., 2003; Zeidan et al., 2012; Torrents-Rodas et al.,
2014), we hypothesized that patients who have been treated for an
anxiety disorder in the past would display stronger fear responses
to threat cue and context, and stronger fear generalization during
extinction as compared to healthy controls. The present (startle
and subjective fearfulness) data do not support this hypothesis,
as no diﬀerences in the rate of fear extinction and the expression
of fear during extinction were found between treated anxiety
patients and control subjects.
However, FPS results demonstrated an association between
high anxiety symptoms over the past week (as measured using
the BAI) and impaired fear extinction across subjects. More
speciﬁcally, during late extinction, subjects with high anxiety
symptoms displayed stronger (cue-speciﬁc and generalization)
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FIGURE 6 | Fear acquisition and extinction of subjective fearfulness shown across all participants and displayed separately for shock room light,
shock room dark, safe room light, and safe room dark. No significant differences in subjective fearfulness were found between treated anxiety patients and
control subjects. Error bars show ±1 SEM.
FPS as compared to those with low anxiety symptoms. This
ﬁnding reﬂects that during extinction, in which the cue does
not predict the occurrence of danger anymore, high levels of
anxiety symptoms are associated with stronger fear responses
to the threat cue. These results suggest that fear extinction
is predominantly associated with anxiety symptoms directly
preceding or at the time of testing, and, in line with a dimensional
approach (RDoC initiative; Insel et al., 2010), is not restricted to
previous or current anxiety disorder diagnosis. Furthermore, the
ﬁnding that BAI, but not a diagnosis of an anxiety disorder in
the past, is signiﬁcantly associated with fear extinction suggests
that even though fear extinction is relatively stable over time
and partly determined by genetics (Fredrikson et al., 1993;
Hettema et al., 2003; Zeidan et al., 2012; Torrents-Rodas et al.,
2014), the circuitry underlying fear extinction is dynamic. Meta-
analyses have shown signiﬁcant diﬀerences between individuals
with a current anxiety diagnosis and control subjects (Lissek
et al., 2005; Duits et al., 2015), but the current ﬁndings may
reﬂect plasticity due to new learning experiences, especially
in the context of an exposure therapy. Due to the similarity
of fear extinction to processes putatively underlying exposure
therapy (Massad and Hulsey, 2006; Hofmann, 2008; Myers and
Davis, 2008), fear extinction performance might be improved by
exposure therapy, the treatment of choice in anxiety disorders.
Neuroimaging studies provide evidence for stronger activation
of the ventromedial prefrontal cortex, an area important in
extinction, after just one session of exposure therapy (Schienle
et al., 2007). Results from exploratory analyses in the current
study demonstrated no signiﬁcant diﬀerence in fear conditioning
between treatment responders and non-responders. However, the
time between treatment and participation in the conditioning
paradigm had been variable, and sample sizes were small.
Furthermore, data from the current study did not allow the
examination of changes in fear extinction before and after
treatment, as no pre-treatment measurement of fear extinction
was included. Therefore, further conclusions must await a
prospective study that includes pretreatment fear extinction
measures to determine whether fear extinction is improved by
successful exposure therapy. Nevertheless, the present results
allow the conclusion that the current anxiety status seems to have
more impact on fear extinction mechanisms than a past anxiety
diagnosis.
Subjective fearfulness ratings did not show a similar pattern,
demonstrating no diﬀerences in fear extinction between subjects
reporting high vs. low anxiety symptoms. A recent meta-
analysis found no diﬀerence in sensitivity of physiological vs.
subjective outcome measures to fear conditioning and extinction
abnormalities in anxiety patients vs. controls (Duits et al., 2015).
Yet, in this study the FPS outcome parameter was sensitive
to individual diﬀerences in current anxiety symptoms, while
subjective ratings were not. This is in line with numerous studies
in which pharmacological manipulations or genetic analyses
demonstrate eﬀects on physiological parameters in absence of
eﬀects on subjective reports (Kindt et al., 2009; Soeter and Kindt,
2011; Heitland et al., 2012, 2013; Klumpers et al., 2012; Baas and
Heitland, 2014). This may reﬂect a closer relationship between
physiological parameters (relative to subjective reports) and the
neurobiological circuitry that is aﬀected, while subjective reports
are more susceptible to cognitive evaluation and experimenter
demand (Boddez et al., 2013).
Caution is required when interpreting the current ﬁndings, as
several limitations should be taken into account. First, the current
study did not control for potential diﬀerences in fear extinction
between anxiety patients and controls prior to exposure therapy,
as diﬀerences were only investigated after patients had received
treatment. We therefore recommend to include both pre- and
post-treatment measurements of extinction in future studies.
Second, replication of the current study is recommended in a
larger sample, thereby allowing to examine diﬀerences across
diagnostic groups (patients with panic disorder vs. social anxiety).
So far, our meta-analysis (Duits et al., 2015) and recent ﬁndings
from our group (Duits et al., in preparation) found no support
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for signiﬁcant diﬀerences in fear conditioning across diagnostic
groups. Third, the conditioning procedure would beneﬁt from
the inclusion of at least one additional CS in both contexts that
is never paired with the US, to measure generalization eﬀects and
to further specify the eﬀects of cue conditioning. Fourth, we did
not formally test hearing acuity and drug use in participants.
CONCLUSION
No signiﬁcant diﬀerences in fear extinction were found
between treated anxiety patients and healthy controls, but
stronger generalization and cue-speciﬁc fear potentiation were
demonstrated during late extinction in subjects with high
compared to low anxiety symptoms over the past week. Together,
these results may suggest that current anxiety symptoms rather
than past anxiety disorder diagnosis may play an impairing
role in fear extinction processes. This should be taken into
account in future fear conditioning paradigms. The anxiety
symptoms as assessed with the BAI may represent a dimensional
variable that relates closely to fear extinction and that cuts
across diﬀerent diagnostic categories within the anxiety disorder
spectrum. In addition, future prospective longitudinal studies
are needed to shed light on the course of individual diﬀerences
in fear extinction and to further investigate whether persistence
of impaired fear extinction is a risk factor that mediates future
relapse in anxiety disordered patients after treatment.
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